Yahoo Web Search

Search results

  1. Hongliang Wu's 5 research works with 22 citations and 406 reads, including: The feasibility and safety of complete laparoscopic extended right hemicolectomy with preservation of the ileocecal...

  2. Aug 1, 2005 · Hongliang Wu. How many people are using ORCID?

  3. Hongliang WU of University of Washington Seattle, Seattle (UW) | Contact Hongliang WU

  4. May 8, 2022 · Abstract. Objective: China and the United States (the U.S.) have the heaviest colorectal cancer (CRC) burden with considerable variations in temporal trends. This study aims to analyze the temporal patterns of CRC burden and its risk factors in China and the U.S. across the past three decades.

  5. View HONGLIANG WUs profile on LinkedIn, the world’s largest professional community. HONGLIANG has 4 jobs listed on their profile. See the complete profile on LinkedIn and discover...

    • Wublockchain 吴说
    • Hong Kong, Hong Kong SAR
  6. Aug 10, 2022 · Studies have shown that the prognosis of patients with ASS with positive anti-PL7 and anti-PL12 antibodies is poor, and the survival rate is lower than that of patients with positive anti-Jo1 antibodies ( 3, 7 ). Lung involvement is one of the main risk factors for poor survival.

  7. Hongliang Wu's 3 research works with 1 citations and 38 reads, including: Mechanism of vascular endothelial cell-derived exosomes modified with vascular endothelial growth factor in steroid...